Use of Antiseptic Solution for Vaginal Wash Before Cesarean Section
NCT ID: NCT03442218
Last Updated: 2019-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
203 participants
INTERVENTIONAL
2017-06-01
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clorhexidine
Vaginal wash with clorhexidine solution
Clorhexidine
Vaginal wash with clorhexidine solution previous to cesarean section in patients with premature rupture of membranes.
Saline solution
Vaginal wash with saline solution
Saline solution
Vaginal wash with saline solution previous to cesarean section in patients with premature rupture of membranes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clorhexidine
Vaginal wash with clorhexidine solution previous to cesarean section in patients with premature rupture of membranes.
Saline solution
Vaginal wash with saline solution previous to cesarean section in patients with premature rupture of membranes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Premature rupture of membranes (\> 6 hours).
* Use of prophylactic antibiotic 1 hour previous to cesarean section.
Exclusion Criteria
* Fever of unknown origin previous to surgery.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sistema Nacional de Investigación (SNI) - Panamá
UNKNOWN
Saint Thomas Hospital, Panama
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osvaldo A. Reyes T.
Head - Research Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Thomas Maternity Hospital
Panama City, , Panama
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Urena N, Reyes O. Preoperative vaginal cleansing with chlorhexidine vs placebo in patients with rupture of membranes: a prospective, randomized, double-blind, placebo-control study. Am J Obstet Gynecol MFM. 2022 Mar;4(2):100572. doi: 10.1016/j.ajogmf.2022.100572. Epub 2022 Jan 17.
Haas DM, Morgan S, Contreras K, Kimball S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2020 Apr 26;4(4):CD007892. doi: 10.1002/14651858.CD007892.pub7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHST2014-20
Identifier Type: -
Identifier Source: org_study_id